For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
As of close of business last night, Cellebrite DI Ltd’s stock clocked out at $24.00, up 0.17% from its previous closing price of $23.96. In other words, the price has increased by $0.17 from its previous closing price. On the day, 0.8 million shares were traded. CLBT stock price reached its highest trading level at $24.38 during the session, while it also had its lowest trading level at $23.83.
Ratios:
To gain a deeper understanding of CLBT’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 13.47 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 48.78. For the most recent quarter (mrq), Quick Ratio is recorded 1.78 and its Current Ratio is at 1.81. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Needham on March 28, 2024, Reiterated its Buy rating but revised its target price to $13.50 from $13 previously.
BofA Securities Upgraded its Neutral to Buy on February 16, 2024, whereas the target price for the stock was revised from $9 to $12.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jan 15 ’25 when YOSEF CARMIL bought 200,000 shares for $22.28 per share.
DAVID GEE bought 4,263 shares of CLBT for $95,960 on Dec 27 ’24. On Dec 11 ’24, another insider, Aliazar Keinan, who serves as the Director of the company, bought 19,385 shares for $19.89 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLBT now has a Market Capitalization of 5156232192 and an Enterprise Value of 4650432000. For the stock, the TTM Price-to-Sale (P/S) ratio is 12.97 while its Price-to-Book (P/B) ratio in mrq is 16.74. Its current Enterprise Value per Revenue stands at 12.074 whereas that against EBITDA is 69.237.
Stock Price History:
The Beta on a monthly basis for CLBT is 1.47, which has changed by 1.6015201 over the last 52 weeks, in comparison to a change of 0.21794415 over the same period for the S&P500. Over the past 52 weeks, CLBT has reached a high of $24.62, while it has fallen to a 52-week low of $8.91. The 50-Day Moving Average of the stock is 12.31%, while the 200-Day Moving Average is calculated to be 49.59%.
Shares Statistics:
It appears that CLBT traded 1.46M shares on average per day over the past three months and 1753900 shares per day over the past ten days. A total of 208.08M shares are outstanding, with a floating share count of 86.02M. Insiders hold about 58.66% of the company’s shares, while institutions hold 38.85% stake in the company. Shares short for CLBT as of 1736899200 were 1137208 with a Short Ratio of 0.78, compared to 1734048000 on 1025534. Therefore, it implies a Short% of Shares Outstanding of 1137208 and a Short% of Float of 1.0199999.
